Thus, 1,25(OH)2D3 may exert a mitigating action on the intrinsic pro-inflammatory characteristics of IFN-DC which are potentially harmful in the context of MS, such as the expression of high levels of IL8 or MMP9. The gene discussed is MMP9; the disease is myeloid sarcoma.